Nontobeko P. Mncwangi
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Nontobeko P. Mncwangi has a total of 15 co-authors. Here are the top co-authors by number of shared publications:
- Xavier Siwe Noundou
Department of Pharmaceutical Sciences, School of Pharmacy, Sefako Makgatho Health Sciences University, Pretoria, South Africa
3 shared publications - Bwalya Angel Witika
Department of Pharmaceutical Sciences, School of Pharmacy, Sefako Makgatho Health Sciences University, Pretoria 0208, South Africa
2 shared publications - Tanaka Ndongwe
Department of Pharmaceutical Sciences School of Pharmacy Sefako Makgatho Health Sciences University P.O. BOX 218, MEDUNSA Pretoria 0204 South Africa
2 shared publications - Babalwa Tembeni
African Genome Center, Mohammed VI Polytechnic University, Lot 660, Hay Moulay Rachid, Ben Guerir 43150, Morocco
1 shared publication - Beverley Summers
Department of Pharmaceutical Sciences, School of Pharmacy, Sefako Makgatho Health Sciences University, P.O. Box 218, Medunsa 0204, South Africa
1 shared publication - Gauda Mahlatsi
School of Pharmacy, Department of Pharmacy Practice, Sefako Makgatho Health Sciences University, P.O. Box 218, Medunsa, Pretoria 0204, South Africa
1 shared publication
Latest Publications
- Open Access
- 31 March 2025
- Published by MDPI AG in Pharmaceuticals
- Vol. 18 (4) , 513
Selected Medicinal Plants Used in the Treatment and Management of Tuberculosis and Related Symptoms in South Africa
Background/Objectives: Medicinal plants are used around the globe to treat and/or manage various medical conditions, including respiratory diseases such as tuberculosis, which affect the lower respiratory tract, with its related symptoms being treated and/or managed using medicinal plants. This review collates the available literature pertaining to the medicinal uses and phytochemistry of Carpobrotus edulis, Drosera capensis, Pelargonium reniforme, and Tulbaghia violacea used for the treatment and management of tuberculosis in South Africa. The abovementioned plants were selected based on their long history of use, anecdotal evidence, and the scientific data available. Methods: Data to compile this review article were sourced and analyzed from Google Scholar, Pubmed, ScienceDirect, and textbooks published from 2000 to 2022. The search terms included the plant and genus names of each species, tuberculosis, and Mycobacterium tuberculosis. Results: The data obtained indicate that the plants do not only have an effect on Mycobacterium tuberculosis, but also on other conditions, including cough, colds, eczema, infections, and asthma, which are differential diagnoses in suspected tuberculosis cases. The literature indicates that extracts from the four plants under review have antimicrobial activity, with MICs ranging between 0.20 and 50.00 mg/mL. The major classes of phytochemicals identified from the four medicinal plants included flavonoids, naphthoquinone, terpenoids, and sulfur-containing compounds. Conclusions: The literature review on the plants reveals that they are also used to treat other lower-respiratory ailments, including cough and fever, which may be signs and symptoms of TB. The literature review reveals that medicinal plants contain valuable phytochemicals which may be strong drug leads to combat the tuberculosis epidemic.
- 31 March 2025
- Published by MDPI AG in Pharmaceuticals
- Vol. 18 (4) , 513
Open AccessSelected Medicinal Plants Used in the Treatment and Management of Tuberculosis and Related Symptoms in South Africa
Background/Objectives: Medicinal plants are used around the globe to treat and/or manage various medical conditions, including respiratory diseases such as tuberculosis, which affect the lower respiratory tract, with its related symptoms being treated and/or managed using medicinal plants. This review collates the available literature pertaining to the medicinal uses and phytochemistry of Carpobrotus edulis, Drosera capensis, Pelargonium reniforme, and Tulbaghia violacea used for the treatment and management of tuberculosis in South Africa. The abovementioned plants were selected based on their long history of use, anecdotal evidence, and the scientific data available. Methods: Data to compile this review article were sourced and analyzed from Google Scholar, Pubmed, ScienceDirect, and textbooks published from 2000 to 2022. The search terms included the plant and genus names of each species, tuberculosis, and Mycobacterium tuberculosis. Results: The data obtained indicate that the plants do not only have an effect on Mycobacterium tuberculosis, but also on other conditions, including cough, colds, eczema, infections, and asthma, which are differential diagnoses in suspected tuberculosis cases. The literature indicates that extracts from the four plants under review have antimicrobial activity, with MICs ranging between 0.20 and 50.00 mg/mL. The major classes of phytochemicals identified from the four medicinal plants included flavonoids, naphthoquinone, terpenoids, and sulfur-containing compounds. Conclusions: The literature review on the plants reveals that they are also used to treat other lower-respiratory ailments, including cough and fever, which may be signs and symptoms of TB. The literature review reveals that medicinal plants contain valuable phytochemicals which may be strong drug leads to combat the tuberculosis epidemic.
- Open Access
Iridoid Derivatives as Anticancer Agents: An Updated Review from 1970–2022
The rise of cancer cases has coincided with the urgent need for the development of potent chemical entities and/or modification of existing commodities to improve their efficacy. Increasing evidence suggests that cancer remains one of the leading causes of death globally, with colon cancer cases alone likely to rise exponentially by 2030. The exponential rise in cancer prevalence is largely attributable to the growing change toward a sedentary lifestyle and modern diets, which include genetically modified foods. At present, the prominent treatments for cancer are chemotherapy, surgery, and radiation. Despite slowing cancer progression, these treatments are known to have devastating side effects that may deteriorate the health of the patient, thus, have a low risk–benefit ratio. In addition, many cancer drugs have low bioavailability, thereby limiting their therapeutic effects in cancer patients. Moreover, the drastic rise in the resistance of neoplastic cells to chemotherapeutic agents is rendering the use of some drugs ineffective, thereby signaling the need for more anticancer chemical entities. As a result, the use of natural derivatives as anticancer agents is gaining considerable attention. Iridoids have the potential to form conjugates with other anticancer, antidiabetic, antileishmanial, and antimalarial drugs, which synergistically have the potential to increase their effects. Published studies have identified the role of iridoids, which, if fully explored, may result in cheaper and less toxic alternative/adjuvant cancer drugs. The subject of this article is natural and synthetic iridoid derivatives and their potential therapeutic roles as anticancer agents.
Open AccessIridoid Derivatives as Anticancer Agents: An Updated Review from 1970–2022
The rise of cancer cases has coincided with the urgent need for the development of potent chemical entities and/or modification of existing commodities to improve their efficacy. Increasing evidence suggests that cancer remains one of the leading causes of death globally, with colon cancer cases alone likely to rise exponentially by 2030. The exponential rise in cancer prevalence is largely attributable to the growing change toward a sedentary lifestyle and modern diets, which include genetically modified foods. At present, the prominent treatments for cancer are chemotherapy, surgery, and radiation. Despite slowing cancer progression, these treatments are known to have devastating side effects that may deteriorate the health of the patient, thus, have a low risk–benefit ratio. In addition, many cancer drugs have low bioavailability, thereby limiting their therapeutic effects in cancer patients. Moreover, the drastic rise in the resistance of neoplastic cells to chemotherapeutic agents is rendering the use of some drugs ineffective, thereby signaling the need for more anticancer chemical entities. As a result, the use of natural derivatives as anticancer agents is gaining considerable attention. Iridoids have the potential to form conjugates with other anticancer, antidiabetic, antileishmanial, and antimalarial drugs, which synergistically have the potential to increase their effects. Published studies have identified the role of iridoids, which, if fully explored, may result in cheaper and less toxic alternative/adjuvant cancer drugs. The subject of this article is natural and synthetic iridoid derivatives and their potential therapeutic roles as anticancer agents.
- Open Access
A Review on Pharmacy Practice in South Africa—A Higher Education Perspective
In April 1994, South Africa underwent the most significant change in its recent history with the disbandment of the policy of apartheid and the attendant race-based politics, which affected most aspects of the country and, of relevance to this review, the education, health delivery, and career choices that race groups could pursue. In the past 28 years, the South African government has tried to implement policies in order to advance political and socioeconomic shifts toward a more equitable society. The healthcare sector was an early target for transformation that was aimed at increasing access to services and the expansion of primary healthcare and hospital facilities to previously underserved areas. This paper seeks to discuss these changes in broad terms, but with specific reference to general health care and pharmacy practice in particular. It will look at the changes in the legislative framework and pharmacy education and factors impacting the pharmacy practices in South Africa over the past 28 years. A discussion of the critical issues that have affected the profession in the last three decades will also be delineated, and future prospects for the profession as a whole, in terms of pharmacy practice and perspectives, will be discussed. We review the current aspects of the pharmacy profession in South Africa today and how the education of those future professionals is a major contribution to the pharmaceutical climate.
Open AccessA Review on Pharmacy Practice in South Africa—A Higher Education Perspective
In April 1994, South Africa underwent the most significant change in its recent history with the disbandment of the policy of apartheid and the attendant race-based politics, which affected most aspects of the country and, of relevance to this review, the education, health delivery, and career choices that race groups could pursue. In the past 28 years, the South African government has tried to implement policies in order to advance political and socioeconomic shifts toward a more equitable society. The healthcare sector was an early target for transformation that was aimed at increasing access to services and the expansion of primary healthcare and hospital facilities to previously underserved areas. This paper seeks to discuss these changes in broad terms, but with specific reference to general health care and pharmacy practice in particular. It will look at the changes in the legislative framework and pharmacy education and factors impacting the pharmacy practices in South Africa over the past 28 years. A discussion of the critical issues that have affected the profession in the last three decades will also be delineated, and future prospects for the profession as a whole, in terms of pharmacy practice and perspectives, will be discussed. We review the current aspects of the pharmacy profession in South Africa today and how the education of those future professionals is a major contribution to the pharmaceutical climate.
- Open Access
- 10 November 2022
- Published by MDPI AG in Pharmaceutics
- Vol. 14 (11) , 2437
The Use of Medicinal Plant-Derived Metallic Nanoparticles in Theranostics
In the quest to effectively diagnose and treat the diseases that afflict mankind, the development of a tool capable of simultaneous detection and treatment would provide a significant cornerstone for the survival and control of these diseases. Theranostics denotes a portmanteau of therapeutics and diagnostics which simultaneously detect and treat ailments. Research advances have initiated the advent of theranostics in modern medicine. Overall, theranostics are drug delivery systems with molecular or targeted imaging agents integrated into their structure. The application of theranostics is rising exponentially due to the urgent need for treatments that can be utilized for diagnostic imaging as an aid in precision and personalised medicine. Subsequently, the emergence of nanobiotechnology and the green synthesis of metallic nanoparticles (MNPs) has provided one such avenue for nanoscale development and research. Of interest is the drastic rise in the use of medicinal plants in the synthesis of MNPs which have been reported to be potentially effective in the diagnosis and treatment of diseases. At present, medicinal plant-derived MNPs have been cited to have broad pharmacological applications and have been studied for their potential use in the treatment and management of cancer, malaria, microbial and cardiovascular diseases. The subject of this article regards the role of medicinal plants in the synthesis of MNPs and the potential role of MNPs in the field of theranostics.
- 10 November 2022
- Published by MDPI AG in Pharmaceutics
- Vol. 14 (11) , 2437
Open AccessThe Use of Medicinal Plant-Derived Metallic Nanoparticles in Theranostics
In the quest to effectively diagnose and treat the diseases that afflict mankind, the development of a tool capable of simultaneous detection and treatment would provide a significant cornerstone for the survival and control of these diseases. Theranostics denotes a portmanteau of therapeutics and diagnostics which simultaneously detect and treat ailments. Research advances have initiated the advent of theranostics in modern medicine. Overall, theranostics are drug delivery systems with molecular or targeted imaging agents integrated into their structure. The application of theranostics is rising exponentially due to the urgent need for treatments that can be utilized for diagnostic imaging as an aid in precision and personalised medicine. Subsequently, the emergence of nanobiotechnology and the green synthesis of metallic nanoparticles (MNPs) has provided one such avenue for nanoscale development and research. Of interest is the drastic rise in the use of medicinal plants in the synthesis of MNPs which have been reported to be potentially effective in the diagnosis and treatment of diseases. At present, medicinal plant-derived MNPs have been cited to have broad pharmacological applications and have been studied for their potential use in the treatment and management of cancer, malaria, microbial and cardiovascular diseases. The subject of this article regards the role of medicinal plants in the synthesis of MNPs and the potential role of MNPs in the field of theranostics.